1-3 of 3
M. Marquesen
Close
Sort by
Journal Articles

A phase 1 clinical trial of long-term, low-dose treatment of WHIM syndrome with the CXCR4 antagonist plerixafor

Clinical Trials & Observations
David H. McDermott, Qian Liu, Daniel Velez, Lizbeeth Lopez, Sandra Anaya-O’Brien, Jean Ulrick, Nana Kwatemaa, Judy Starling, Thomas A. Fleisher, Debra A. Long Priel, Melissa A. Merideth, Robert L. Giuntoli, Moses O. Evbuomwan, Patricia Littel, Martha M. Marquesen, Dianne Hilligoss, Rosamma DeCastro, George J. Grimes, Samuel T. Hwang, Stefania Pittaluga, Katherine R. Calvo, Pamela Stratton, Edward W. Cowen, Douglas B. Kuhns, Harry L. Malech, Philip M. Murphy
Journal: Blood
Blood (2014) 123 (15): 2308–2316.
https://doi.org/10.1182/blood-2013-09-527226
Published: 2014
Includes: Supplemental data
Journal Articles

The CXCR4 antagonist plerixafor corrects panleukopenia in patients with WHIM syndrome

Clinical Trials & Observations
David H. McDermott, Qian Liu, Jean Ulrick, Nana Kwatemaa, Sandra Anaya-O'Brien, Scott R. Penzak, Joao Oliveira Filho, Debra A. Long Priel, Corin Kelly, Mary Garofalo, Patricia Littel, Martha M. Marquesen, Diane Hilligoss, Rosamma DeCastro, Thomas A. Fleisher, Douglas B. Kuhns, Harry L. Malech, Philip M. Murphy
Journal: Blood
Blood (2011) 118 (18): 4957–4962.
https://doi.org/10.1182/blood-2011-07-368084
Published: 2011
Includes: Supplemental data
Journal Articles

Durable Engraftment and Long-Term Survival Following Fludarabine-Based Nonmyeloablative Hematopoietic Cell Transplantation (HCT) in Patients with ATG-Refractory Severe Aplastic Anemia (SAA) and Other Nonmalignant Hematological Disorders.

Sakti Chakrabarti, Y. Takahashi, R. Srinivasan, I. Espinoza, T. Igarashi, D. Suffredini, M. Marquesen, R. A. Shalabi, C. D. Bolan, S. F. Leitman, A. J. Barrett, N. S. Young, R. Childs
Journal: Blood
Blood (2004) 104 (11): 252.
https://doi.org/10.1182/blood.V104.11.252.252
Published: 2004